ACS Combinatorial Science p. 444 - 455 (2016)
Update date:2022-08-04
Topics:
Myers, Stephanie M.
Bawn, Ruth H.
Bisset, Louise C.
Blackburn, Timothy J.
Cottyn, Betty
Molyneux, Lauren
Wong, Ai-Ching
Cano, Celine
Clegg, William
Harrington, Ross. W.
Leung, Hing
Rigoreau, Laurent
Vidot, Sandrine
Golding, Bernard T.
Griffin, Roger J.
Hammonds, Tim
Newell, David R.
Hardcastle, Ian R.
The extracellular-related kinase 5 (ERK5) is a promising target for cancer therapy. A high-throughput screen was developed for ERK5, based on the IMAP FP progressive binding system, and used to identify hits from a library of 57-617 compounds. Four distinct chemical series were evident within the screening hits. Resynthesis and reassay of the hits demonstrated that one series did not return active compounds, whereas three series returned active hits. Structure-activity studies demonstrated that the 4-benzoylpyrrole-2-carboxamide pharmacophore had excellent potential for further development. The minimum kinase binding pharmacophore was identified, and key examples demonstrated good selectivity for ERK5 over p38α kinase.
View Morewebsite:http://www.mascot-ie.com
Contact:86-519-85010339
Address:B-802,XingBei Building,391#,Tongjiang Middle Road New District,Changzhou,JS,China
Contact:021-36356756
Address:Room601,Building No.14,280 Yangcheng Road,Shanghai
Contact:+86-25-52346955
Address:199,JIANYE ROAD,NANJING,CHINA
Jinan Kaypharm Chemical Co.,Ltd
Contact:86-0531-86986780
Address:Room101,No189-2,Huayuan Road,Jinan City,Shandong Province
Contact:13120882795;+86-21-34621078;+86-021-31122318
Address:Suite 2,No.2715 Longwu Road
Doi:10.1111/j.2042-7158.1979.tb13528.x
(1979)Doi:10.1039/P19810000947
(1981)Doi:10.1016/j.tetlet.2006.07.156
(2006)Doi:10.1021/jm00324a019
(1966)Doi:10.1002/anie.201802563
(2018)Doi:10.1039/jr9460000729
(1946)